172 related articles for article (PubMed ID: 17050664)
1. Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer.
Chen C; Seth AK; Aplin AE
Mol Cancer Res; 2006 Oct; 4(10):695-707. PubMed ID: 17050664
[TBL] [Abstract][Full Text] [Related]
2. The Nedd4-like family of E3 ubiquitin ligases and cancer.
Chen C; Matesic LE
Cancer Metastasis Rev; 2007 Dec; 26(3-4):587-604. PubMed ID: 17726579
[TBL] [Abstract][Full Text] [Related]
3. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
Liu L; Wong CC; Gong B; Yu J
Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
[TBL] [Abstract][Full Text] [Related]
4. The suppressors of cytokine signalling E3 ligases behave as tumour suppressors.
Elliott J; Hookham MB; Johnston JA
Biochem Soc Trans; 2008 Jun; 36(Pt 3):464-8. PubMed ID: 18481982
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin ligases in oncogenic transformation and cancer therapy.
Senft D; Qi J; Ronai ZA
Nat Rev Cancer; 2018 Feb; 18(2):69-88. PubMed ID: 29242641
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers.
Horie-Inoue K; Inoue S
Semin Cancer Biol; 2006 Jun; 16(3):235-9. PubMed ID: 16682214
[TBL] [Abstract][Full Text] [Related]
7. A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer.
Burger AM; Gao Y; Amemiya Y; Kahn HJ; Kitching R; Yang Y; Sun P; Narod SA; Hanna WM; Seth AK
Cancer Res; 2005 Nov; 65(22):10401-12. PubMed ID: 16288031
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligases.
Ardley HC; Robinson PA
Essays Biochem; 2005; 41():15-30. PubMed ID: 16250895
[TBL] [Abstract][Full Text] [Related]
9. Role of E3 ubiquitin ligases in gastric cancer.
Hou YC; Deng JY
World J Gastroenterol; 2015 Jan; 21(3):786-93. PubMed ID: 25624711
[TBL] [Abstract][Full Text] [Related]
10. Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma.
Hellwinkel OJ; Asong LE; Rogmann JP; Sültmann H; Wagner C; Schlomm T; Eichelberg C
Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):38-45. PubMed ID: 21102547
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive phenotypic CRISPR-Cas9 screen of the ubiquitin pathway uncovers roles of ubiquitin ligases in mitosis.
Hundley FV; Sanvisens Delgado N; Marin HC; Carr KL; Tian R; Toczyski DP
Mol Cell; 2021 Mar; 81(6):1319-1336.e9. PubMed ID: 33539788
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin ligases and medulloblastoma: genetic markers of the four consensus subgroups identified through transcriptome datasets.
Vriend J; Rastegar M
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165839. PubMed ID: 32445667
[TBL] [Abstract][Full Text] [Related]
13. E3 ubiquitin ligases as cancer targets and biomarkers.
Sun Y
Neoplasia; 2006 Aug; 8(8):645-54. PubMed ID: 16925947
[TBL] [Abstract][Full Text] [Related]
14. Novel RING E3 ubiquitin ligases in breast cancer.
Burger A; Amemiya Y; Kitching R; Seth AK
Neoplasia; 2006 Aug; 8(8):689-95. PubMed ID: 16925951
[TBL] [Abstract][Full Text] [Related]
15. The role of aberrant proteolysis in lymphomagenesis.
Sahasrabuddhe AA; Elenitoba-Johnson KS
Curr Opin Hematol; 2015 Jul; 22(4):369-78. PubMed ID: 26049759
[TBL] [Abstract][Full Text] [Related]
16. SLIM trims STATs: ubiquitin E3 ligases provide insights for specificity in the regulation of cytokine signaling.
Ungureanu D; Silvennoinen O
Sci STKE; 2005 Oct; 2005(304):pe49. PubMed ID: 16204702
[TBL] [Abstract][Full Text] [Related]
17. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
[TBL] [Abstract][Full Text] [Related]
18. [Cytogenetic abnormalities, genetic alterations, and applications for genetic diagnosis in breast cancer].
Tsukamoto K; Emi M; Nakamura Y
Nihon Rinsho; 1996 Dec; 54(12):3389-97. PubMed ID: 8976125
[TBL] [Abstract][Full Text] [Related]
19. The role and therapeutic implications of RING-finger E3 ubiquitin ligases in hepatocellular carcinoma.
Yin J; Zhu JM; Shen XZ
Int J Cancer; 2015 Jan; 136(2):249-57. PubMed ID: 24420637
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'.
Yamasaki S; Yagishita N; Sasaki T; Nakazawa M; Kato Y; Yamadera T; Bae E; Toriyama S; Ikeda R; Zhang L; Fujitani K; Yoo E; Tsuchimochi K; Ohta T; Araya N; Fujita H; Aratani S; Eguchi K; Komiya S; Maruyama I; Higashi N; Sato M; Senoo H; Ochi T; Yokoyama S; Amano T; Kim J; Gay S; Fukamizu A; Nishioka K; Tanaka K; Nakajima T
EMBO J; 2007 Jan; 26(1):113-22. PubMed ID: 17170702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]